NDC Code | 17312-021-14 |
Package Description | 1 BOTTLE in 1 PACKAGE (17312-021-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE |
Product NDC | 17312-021 |
Product Type Name | HUMAN OTC DRUG |
Proprietary Name | Sciatica Therapy |
Non-Proprietary Name | Arnica Montana - Citrullus Colocynthis Fruit Pulp - Pseudognaphalium Obtusifolium - Hypericum Perforatum - Potassium Iodide - Magnesium Phosphate, Dibasic Trihydrate - Toxicodendron Pubescens Leaf - |
Dosage Form | TABLET, ORALLY DISINTEGRATING |
Usage | ORAL |
Start Marketing Date | 20111201 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Manufacturer | TRP Company |
Substance Name | ARNICA MONTANA; CITRULLUS COLOCYNTHIS FRUIT PULP; HYPERICUM PERFORATUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM IODIDE; PSEUDOGNAPHALIUM OBTUSIFOLIUM; TOXICODENDRON PUBESCENS LEAF |
Strength | 6; 6; 6; 6; 6; 6; 6 |
Strength Unit | [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 |
Pharmacy Classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |